Research Publications - 2021
- – Medical Image Analysis
Quantifying Parkinson’s disease motor severity under uncertainty using MDS-UPDRS videos
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease. It affects motor function and commonly causes slowing of movements and stiffness. PD is caused by a gradual decline in dopamine production, resulting in progressive deterioration of selective brain neurons. The degeneration of dopamine-containing cells in the basal ganglia regions provoke visible signs of gait disturbances and postural instabilities. Early PD diagnosis and tracking of its signs are crucial for the development and maintenance of treatment plans.
- – NEJM Catalyst
A Cost Comparison of Cataract Surgeries in Three Countries — United States, India, and Nepal
Significant savingsmay be achieved in the United States through adoption of these practices, but it may require new incentives within the nation’s health system.
- – NEJM
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
CERC’s Kevin Schulman et al: In the NIH-sponsored C3PO clinical trial, high-risk patients with mild to moderate symptoms showed little benefit from Covid-19 convalescent plasma.
- – JAMA Open Network
Evaluation of Clinical and Economic Outcomes Following Implementation of a Centers for Medicare and Medicaid Services Pay-For-Performance Program for Selected Surgical Procedures
CERC fellow Kyung Mi Kim, PhD, RN, and UCSF colleagues look at the impact of the pay-per-performance policy on both hospital costs and surgical complications.
- – NEJM Catalyst
Leading Health Care Teams Beyond Covid-19: Marking the Moment and Shifting from Recuperation to Regeneration
The post-pandemic era offers health care leaders an opportunity to regenerate their teams, writes CERC’s Sara Singer in NEJM Catalyst
- – JAMA: Viewpoint
Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
CERC's Kevin Schulman, Barak Richman, and Stanford Neurologist Michael Greicius examine what’s at stake in the FDA’s approval of the new Alzheimer’s drug, aducanumab
- – Nature
Using deep learning to identify the recurrent laryngeal nerve during thyroidectomy
This CERC PAC research suggests the potential for deep learning to provide insight to the surgeon about image capture technique for achieving high performance.
- – Autism
Distilling innovative US autism care programs that address widely perceived unmet patient and family needs
CERC’s Venus Wong and team identified 15 collaboratively designed care models that improve the lives of autistic individuals and their families. (HFSC)